Introduction
In this appendix attention is drawn to reports, including those published by the International Commission on Radiological Protection (ICRP), which contain biological data of value in the dosimetry of radionuclides. This appendix is not intended as a guide to individual studies on particular radiopharmaceuticals published in the general literature, but certain reviews of the dosimetry of radiopharmaceuticals, especially those in which the methods recommended here have been used, are cited.
ICRP
The report of Committee 2, ICRP Publication 2 (1959) contains data used by the Committee to calculate values of maximum permissible body burdens and maximum permissible concentrations in air and water for more than 200 radionuclides and for several critical organs and tissues in each case. The mathematical expression used in Publication 2 to describe retention of a radionuclide in a particular tissue is a single exponential. The parameters of these exponentials were chosen so that the time integrals of the expressions over a working lifetime of 50 years approximate to the corresponding time integrals of the functions which accurately describe retention of the radionuclides in the tissue concerned. Frequently a single exponential function cannot describe the whole time course of activity for a particular radionuclide and, therefore, if one uses the data to calculate dose rate in the appropriate tissue at various times after intake, the results will be inaccurate, especially at early times when activity in the tissue is still increasing. However, in principle, the data may be used to calculate the total average dose delivered to tissue in the 50 years following a single intake of a radionuclide; also, in many cases, where elimination of the radionuclide is relatively rapid, the dose will beeffectively delivered in a time much shorter than 50 years. Vennart and Minski (1962) used the data to calculate the mean absorbed doses received by different organs of adult males following the administration of 1 µCi of each of some 50 radionuclides. They also discussed the limitations on use of the data for medical purposes; e.g., the data are for average adult healthy males and corrections have to be made, therefore, when they are used 52 for persons of different age or sex and for persons suffering from diseases which may change the masses of organs and the metabolism of radionuclides. Since radionuclides are classified in the report only into soluble and insoluble forms, the data may not accurately describe retention of different chemical compounds of the same radionuclide.
ICRP Publication 10 (1968) extended the work presented in Publication 2, tabulating physical and biological data for 30 radionuclides, including 15 widely used in medicine. The metabolism for each of the radionuclides is discussed, frequently with reference to particular sets of observations on humans.
ICRP Publication 2 gives details of a "standard man" used as a model for calculations of absorbed dose. ICRP Publication 23 (1975) is a report of a Task Group in which the specifications of the earlier standard man were greatly extended; the Task Group undertook a comprehensive review of the characteristics of ~an "that relate directly or indirectly to intake, metabolism, distribution in the body, and retention of the various isotopes of concern" and from these data formulated "Reference Man".
Appendix B (Table B -1) gives some details of the masses of organs in ICRP Standard Man and Reference Man.
MIRD
The Medical Internal Radiation Dose (MIRD) Committee has prepared a number of reports giving estimates of absorbed dose for particular radiopharmaceuticals. 3 These reports include summaries of biological data, derived from clinical measurements on patients to whom the radiopharmaceuticals have been administered. The calculations of absorbed dose are based chiefly on the anatomical models developed by Snyder and colleagues (Table B-1).
